NSE
Akums Drugs and Pharmaceuticals LimitedAKUMS
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical company engaged in the manufacturing and distribution of various drug products.
| Key products | Pharmaceuticals, including generic drugs and formulations. |
|---|---|
| Geography | Primarily operates in India with a focus on domestic markets. |
| Competitors | Dr Reddy's Laboratories, Cipla Limited |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹195 Cr
Institutional buyers
2 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share
ex 2026-07-03
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹4.8 Cr | 91 | — | — | — | — |
| 2 | AKUMSThis | — | — | — | — | — | — |
| 3 | MOBIKWIK | +₹0 Cr | 12 | — | — | — | — |
| 4 | QUADFUTURE | +₹0 Cr | 34 | — | — | — | — |
| 5 | IRMENERGY | — | — | — | — | — | — |
| 6 | MTNL | — | — | — | — | — | — |
| 7 | GATECH | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Weaknesses
- • Limited product diversification
- • Dependent on a few key products
Opportunities
- • Potential for market expansion in rural areas
- • Increased focus on digital marketing and e-commerce
Threats
- • Rising raw material costs
- • Regulatory changes impacting pharmaceutical industry
AI-generated from our data — verify before relying on it.
- 2026-07-03ActionDividend - Re 1 Per Share/Special Dividend - Rs 2 Per ShareDividend
- 2026-06-16FilingNewspaper Advertisement- Information regarding 22nd AGM and Final & Special DividendCompliance
- 2026-06-10FilingIntimation of Schedule of the investor/analysts meetsInvestor Call
- 2026-06-09FilingAkums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meetInvestor Call
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 1ComplianceNeutral
Newspaper Advertisement- Information regarding 22nd AGM and Final & Special Dividend
Source PDF → - 2
- 2
No bulk/block deals for AKUMS in this window.
Results & transcripts
Financial results
None yet.
News & chatter on AKUMS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.